VYGLXIA Trademark

Trademark Overview


On Friday, March 26, 2021, a trademark application was filed for VYGLXIA with the United States Patent and Trademark Office. The USPTO has given the VYGLXIA trademark a serial number of 90605911. The federal status of this trademark filing is REGISTERED as of Tuesday, June 18, 2024. This trademark is owned by Biohaven Therapeutics Ltd.. The VYGLXIA trademark is filed in the Pharmaceutical Products category with the following description:

Medicated and pharmaceutical preparations, both prescription and over-the-counter, for use in connection with humans and animals, namely, for the treatment of central nervous system disorders, neurologic illnesses, and psychiatric illnesses; pharmaceutical preparations for the treatment of neurodegenerative diseases; pharmaceutical preparations for the treatment of neurodegenerative diseases, namely, Alzheimer's disease (AD), frontotemporal dementia, and cognitive impairment of aging; pharmaceutical preparations for the treatment of pain; pharmaceutical preparations for the treatment of pain, namely, chronic neuropathic pain and peripheral neuropathy; pharmaceutical preparations for symptomatic treatments of degenerative diseases; pharmaceutical preparations for symptomatic treatments of degenerative diseases, namely, dystonias, dysphagia, gait abnormalities, bulbar function in ALS, agitation in AD, and disinhibition in dementia; pharmaceutical preparations for the treatment of neurops...
vyglxia

General Information


Serial Number90605911
Word MarkVYGLXIA
Filing DateFriday, March 26, 2021
Status700 - REGISTERED
Status DateTuesday, June 18, 2024
Registration Number7422444
Registration DateTuesday, June 18, 2024
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 24, 2021

Trademark Statements


Goods and ServicesMedicated and pharmaceutical preparations, both prescription and over-the-counter, for use in connection with humans and animals, namely, for the treatment of central nervous system disorders, neurologic illnesses, and psychiatric illnesses; pharmaceutical preparations for the treatment of neurodegenerative diseases; pharmaceutical preparations for the treatment of neurodegenerative diseases, namely, Alzheimer's disease (AD), frontotemporal dementia, and cognitive impairment of aging; pharmaceutical preparations for the treatment of pain; pharmaceutical preparations for the treatment of pain, namely, chronic neuropathic pain and peripheral neuropathy; pharmaceutical preparations for symptomatic treatments of degenerative diseases; pharmaceutical preparations for symptomatic treatments of degenerative diseases, namely, dystonias, dysphagia, gait abnormalities, bulbar function in ALS, agitation in AD, and disinhibition in dementia; pharmaceutical preparations for the treatment of neuropsychiatric disorders; pharmaceutical preparations for the treatment of neuropsychiatric disorders, namely, Obsessive Compulsive Disorder (OCD) and Generalized Anxiety Disorder (GAD); pharmaceutical preparations for the treatment of cerebellar disorders; pharmaceutical preparations for the treatment of cerebellar disorders, namely, spinocerebellar ataxia

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, July 2, 2021
Primary Code005
First Use Anywhere DateFriday, June 30, 2023
First Use In Commerce DateFriday, June 30, 2023

Trademark Owner History


Party NameBiohaven Therapeutics Ltd.
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressRoad Town, Tortola VG1110
VG

Party NameBiohaven Therapeutics Ltd.
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressRoad Town, Tortola VG1110
VG

Party NameBiohaven Therapeutics Ltd.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressNew Haven, CT 06510

Trademark Events


Event DateEvent Description
Tuesday, March 30, 2021NEW APPLICATION ENTERED
Friday, July 2, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, July 14, 2021ASSIGNED TO EXAMINER
Friday, July 16, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, August 4, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, August 24, 2021PUBLISHED FOR OPPOSITION
Tuesday, August 24, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 19, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Friday, April 15, 2022SOU TEAS EXTENSION RECEIVED
Friday, April 15, 2022SOU EXTENSION 1 FILED
Friday, April 15, 2022SOU EXTENSION 1 GRANTED
Tuesday, April 19, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, October 17, 2022SOU TEAS EXTENSION RECEIVED
Monday, October 17, 2022SOU EXTENSION 2 FILED
Monday, October 17, 2022SOU EXTENSION 2 GRANTED
Wednesday, October 19, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, January 27, 2023SOU TEAS EXTENSION RECEIVED
Friday, January 27, 2023SOU EXTENSION 3 FILED
Friday, January 27, 2023SOU EXTENSION 3 GRANTED
Tuesday, January 31, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, April 17, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, April 17, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, April 17, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, September 19, 2023USE AMENDMENT FILED
Tuesday, September 19, 2023TEAS STATEMENT OF USE RECEIVED
Saturday, September 23, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Saturday, September 23, 2023STATEMENT OF USE PROCESSING COMPLETE
Monday, September 25, 2023SU - NON-FINAL ACTION - WRITTEN
Monday, September 25, 2023NON-FINAL ACTION E-MAILED
Monday, September 25, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, October 3, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, January 4, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, January 4, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, January 4, 2024SU - FINAL REFUSAL - WRITTEN
Thursday, January 4, 2024FINAL REFUSAL E-MAILED
Thursday, January 4, 2024NOTIFICATION OF FINAL REFUSAL EMAILED
Tuesday, January 9, 2024TEAS REQUEST FOR RECONSIDERATION RECEIVED
Friday, May 10, 2024NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Friday, April 26, 2024ASSIGNED TO EXAMINER
Friday, May 10, 2024ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, June 18, 2024REGISTERED-PRINCIPAL REGISTER
Tuesday, June 18, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED